<?xml version="1.0"?>
 <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
   <id>4ba90500-0d03-4762-b37e-c38b4b8eacb1</id>
   <name>VTE Prophylaxis_Surgery Adult Order Panel</name>
   <description>
     <lifecycle_state>Initial</lifecycle_state>
     <details>
       <purpose/>
       <use/>
       <misuse/>
     </details>
     <other_details>
       <item>
         <key>MetaDataSet:Sample Set </key>
         <value>Template metadata sample set </value>
       </item>
       <item>
         <key>Acknowledgements</key>
         <value/>
       </item>
       <item>
         <key>Business Process Level</key>
         <value/>
       </item>
       <item>
         <key>Care setting</key>
         <value/>
       </item>
       <item>
         <key>Client group</key>
         <value/>
       </item>
       <item>
         <key>Clinical Record Element</key>
         <value/>
       </item>
       <item>
         <key>Copyright</key>
         <value/>
       </item>
       <item>
         <key>Issues</key>
         <value/>
       </item>
       <item>
         <key>Owner</key>
         <value/>
       </item>
       <item>
         <key>Sign off</key>
         <value/>
       </item>
       <item>
         <key>Speciality</key>
         <value/>
       </item>
       <item>
         <key>User roles</key>
         <value/>
       </item>
     </other_details>
   </description>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
     <items>
       <item>
         <key>Transform.Technical Notes</key>
         <value>&lt;p&gt;&lt;em&gt;&amp;nbsp;VTE Prophylaxis_Surgery Adult Order Panel&lt;/em&gt;&lt;/p&gt;</value>
       </item>
       <item>
         <key>Technical.ﻩ Technical Traceability</key>
         <value>{~AHSID~4ba90500-0d03-4762-b37e-c38b4b8eacb1~NAME~VTE Prophylaxis_Surgery Adult Order Panel}</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Caprini Score&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;Clinical Decision Support&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Recommendation:&lt;/strong&gt;&amp;nbsp;Patients undergoing major surgery should receive prophylaxis at least during hospital stay and consider extended prophylaxis for those with additional risk factors.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:570px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;Low Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;Non-major surgery in patients less than 40 years old with no risk factors&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Moderate Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Non-major surgery with additional risk factors, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp; Age 40-60 years old&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;High Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Age greater than 60 years old, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; 40-60 years old with additional risk factors&lt;/p&gt;&lt;p&gt;3.&amp;nbsp; Major surgery* in patients aged less than 40 with multiple risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Higher Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients with multiple risk factors or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; Any patient having hip or knee arthroplasty, or:&lt;/p&gt;&lt;p&gt;3.&amp;nbsp; Major trauma or spinal cord injury.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;*major surgery is defined as surgery involving a risk to the life of the patient; specifically an operation upon an organ within the cranium, chest, abdomen, or pelvic cavity&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Major Risk Factors:&amp;nbsp;Major surgery, trauma, ischemic stroke or paralysis, spinal cord injury, previous VTE, congenital and/or acquired thrombophilia states, or active cancer and its treatment&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Minor Risk Factors:&amp;nbsp;Age greater than 40 years, estrogen therapy, nephrotic syndrome, pregnancy/postpartum, prolonged immobility greater than 24 hours, general anesthesia longer than 1 hour, severe respiratory disease, collagen vascular disease, inflammatory bowel disease, congestive heart failure, obesity, sepsis, varicose veins&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Contraindications:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Uncontrolled hypertension, Bleeding disorders (platelets less than 50 x 109/L), Recent intracranial or intraocular hemorrhage, Lumbar puncture within 24 hours, Active bleeding, Heparin-induced thrombocytopenia (HIT)&lt;/p&gt;&lt;p&gt;For patients on heparins, certain drugs can enhance bleeding tendency: acetylsalicylic acid (ASA) and other antiplatelet agents (e.g. clopidogrel, ticagrelor), and nonsteroidal anti-inflammatory drugs (NSAIDs) (particularly ketorolac). This is particularly relevant for patients with intrathecal catheters for analgesia where low molecular weight heparin (LMWH) or unfractionated heparin(UFH ) must NOT be used in conjunction with antiplatelet agents.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Caution –&amp;nbsp;Management of heparins with spinal punctures:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:720px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;width:113px&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&lt;p&gt;Time Before Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Use of anticoagulant in Patients with Indwelling Neuraxial Catheter&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:143px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:143px&quot;&gt;&lt;p&gt;Time After Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Laboratory Tests&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Unfractionated Heparin (UFH) - for prophylaxis, less than 15,000 units /day&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;4 to 6 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Acceptable&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1 hour&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Low Molecular Weight Heparin (LMWH) - for prophylaxis&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;12 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;&lt;p&gt;For single daily dosing –&amp;nbsp;catheter acceptable&lt;/p&gt;&lt;p&gt;(remove catheter 12 hours prior to next dose of LMWH, and subsequent dose should be greater than 4 hours after removal)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;For Twice daily dosing –&amp;nbsp;Do not maintain catheter&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;p&gt;First postoperative dose at least 12 hours after neuraxial puncture and at least 4 hours after removal&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Subsequent dose at least 24 hours after the first dose&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&amp;nbsp;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Warning:&lt;/strong&gt;&lt;span style=&quot;color:inherit&quot;&gt;&amp;nbsp;This is particularly relevant for patients with INTRATHECAL catheters for analgesia where UFH or LMWH must NOT be used in conjunction with antiplatelet agents.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Dose Adjustment: &lt;/strong&gt;Consider adjusting dosage for extremes of weight and renal dysfunction. Adjusted Dosing orders are available in this order set.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;In order to avoid the higher risk of heparin-induced thrombocytopenia, use of unfractionated heparin should be minimized.&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk of Bleeding Contraindications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&amp;nbsp;When bleeding risk decreases, pharmacologic thromboprophylaxis should be substituted for or added to mechanical thromboprophylaxis&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Pre-Op Prophylaxis&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Consider only for patients with very high risk of clotting and lower risk of bleeding such as major cancer surgeries.&lt;br&gt;&amp;nbsp;&lt;br&gt;Patients having neuraxial blockade should only receive unfractionated heparin preop and only after catheter placed&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Pre-Op Prophylaxis&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Delayed Surgery (24+ hours)&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;For patients whose surgery is delayed more than 24 hours&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate - High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate - High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin injection; 4,500 units, subcutaneous, daily, at bedtime&apos;]/activities[at0156]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Moderate - High Risk&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Short Term Therapy&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Enoxaparin should be considered for patients undergoing bariatric surgery, cancer surgery, or trauma surgery, or other situations where there is high bleeding and clotting risk.&lt;br&gt;&amp;nbsp;&lt;br&gt;Select low molecular weight heparin order AND consider ONE additional therapy order:&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Short Term Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Short Term Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Extended Therapy&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Patient undergoing abdominal surgery for cancer should be considered for extended prophylaxis with LMWH or UFH up to four weeks.&lt;br&gt;&amp;nbsp;&lt;br&gt;Higher Risk - Extended Prophylaxis&lt;br&gt;&amp;nbsp;&lt;br&gt;For patients undergoing extensive surgery for abdominal or pelvic cancer, select the tinzaparin order. Also consider selecting ONE of the Additional Therapy orders (Graduated Compression Stockings or Sequential Compression Device):&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Extended Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Extended Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Extended Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Higher Risk - Extended Therapy&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin injection&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Consider selecting &lt;strong&gt;ONE &lt;/strong&gt;of the following additional therapy orders:&amp;nbsp;&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Discharge Instructions/Follow Up&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;VTE prophylaxis on fondaparinux or low molecular weight heparin (LMWH) for 28 days.&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&amp;nbsp;To monitor platelet count for heparin-induced thrombocytopenia (HIT) in heparin-exposed patients with risk of HIT greater than 1%.&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; Avoid intramuscular (IM) injections while receiving anticoagulant therapy.&apos;]/activities[at0156]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; Hold VTE prophylaxis if platelets 50 x 10^9/L or less&apos;]/activities[at0156]">
     <items>
       <item>
         <key>Transform.Preselected</key>
         <value>&lt;p&gt;Y&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis - Surgery Adult">
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Clinical Decision Support">
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
     </Item>
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Treatment Options ">
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="High Risk of Bleeding Contraindications">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="PC Sequential Compression Device Order" max="1" path="/items" name="Sequential Compression Device; Apply, Until discontinued. For patients with a high risk of bleeding, use SCDs at least until the initial risk of bleeding decreases"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="PC AntiEmbolism Stockings Order" max="1" path="/items" name="AntiEmbolism Stockings; Apply, Bilateral, Until discontinued"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Pre-Op Prophylaxis">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Delayed Surgery (24+ hours)">
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin, preservative free injection; 5,000 units, subcutaneous, every 12 hours"/>
         </Item>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Immediate Surgery">
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin, preservative free injection; 5,000 units, subcutaneous, once, Give immediately pre-operatively"/>
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 3,500 units, subcutaneous, once, Give immediately pre-operatively"/>
         </Item>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Post-Op Low Risk">
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8e8fff02-2546-4d47-871c-04a80a00bab8" concept_name="PC Activity Order" max="1" path="/items" name="Activity; Until discontinued, Early ambulation for VTE prophylaxis"/>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Moderate - High Risk">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Anticoagulants">
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis in Major Trauma Patient">
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 4,500 units, subcutaneous, daily, at bedtime"/>
             <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8c50ffc8-0dbe-4b6c-a856-5e03ab6eb2fe" concept_name="PHARM enoxaparin injection Order" max="1" path="/items" name="enoxaparin injection; 30 mg, subcutaneous, every 12 hours, scheduled"/>
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
           </Item>
         </Item>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Renal Dysfunction Dosing">
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge"/>
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin, preservative free injection; (If eGFR +/- Creatinine Clearance LESS than 20 mL/minute) 5,000 units, subcutaneous, every 12 hours, Continue until discharge"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
         </Item>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Higher Risk - Short Term Therapy">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Anticoagulants">
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis in Major Trauma Patient">
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; (adjust for weight less than 40 kg), 4,500 units, subcutaneous, daily, at bedtime"/>
             <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8c50ffc8-0dbe-4b6c-a856-5e03ab6eb2fe" concept_name="PHARM enoxaparin injection Order" max="1" path="/items" name="enoxaparin injection; 30 mg, subcutaneous, every 12 hours, scheduled"/>
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
           </Item>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
         </Item>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Renal Dysfunction Dosing">
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; (adjust for weight less than 40 kg), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge"/>
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin, preservative free injection; (If eGFR +/- Creatinine Clearance LESS than 20 mL/minute) 5,000 units, subcutaneous, every 12 hours, Continue until discharge"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
         </Item>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Higher Risk - Extended Therapy">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin injection">
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis">
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 4,500 units, subcutaneous, daily, at bedtime"/>
             <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
           </Item>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
         </Item>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Renal Dysfunction Dosing">
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; (adjust for weight less than 40 kg), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge"/>
           <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin, preservative free injection; (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute), 5,000 units, subcutaneous, every 12 hours, Continue until discharge"/>
           <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
         </Item>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Additional Therapy">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="PC Sequential Compression Device Order" max="1" path="/items" name="Sequential Compression Device; Apply Bilateral, Recommended for highest risk patients as additional therapy."/>
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="PC AntiEmbolism Stockings Order" max="1" path="/items" name="AntiEmbolism Stockings; Apply Bilateral"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
       </Item>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Discharge Instructions/Follow Up">
         <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a4066b92-bf1d-46a8-9802-d8a62ee534a5" concept_name="PC Discharge activity Order" max="1" path="/items" name="Discharge activity; Medication Instructions, Continue with anticoagulation therapy for a total of 28 days."/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="07af740c-f7eb-4017-9aa2-c688f984867b" concept_name="PC Patient Education (Specify) Order" max="1" path="/items" name="Patient Education (Specify); Prior to discharge, Ensure patient has prescription and teaching provided on injection."/>
         <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
       </Item>
     </Item>
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Routine">
       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential Order" max="1" path="/items" name="CBC, No Differential; Once, To provide baseline platelet count for patients receiving heparin"/>
     </Item>
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Repeating">
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential Order" max="1" path="/items" name="CBC, No Differential; Every 3 days, for 5 occurrences"/>
     </Item>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Avoid intramuscular (IM) injections while receiving anticoagulant therapy."/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Hold VTE prophylaxis if platelets 50 x 10^9/L or less"/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health practioner(MRHP); Notify MRHP if platelets 100 x 10^9/L or less"/>
   </definition>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">
     <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.adhoc_cluster_heading.v1">
     <digest id="MD5-CAM-1.0.1">B87630C57A2DB1AE21050E1105EDE18B</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
     <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
   </integrity_checks>
 </template>